High levels of expression of IFI27 have been reported previously, across different stages of infection (Liu et al., 2022; Palm et al., 2022), and the gene was even put forth as a ‘potential therapeutic target for HIV infection’ based on its downregulation after ART commencement (Huang et al., 2022). The gene discussed is IFI27; the disease is HIV infectious disease.